11.12EUR-2.28%Mkt Cap: 2.39B EURP/E: 58.53Last update: 2026-06-01
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, a…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap2.39B EUR
Enterprise Value2.42B EUR
Revenue (TTM)1.12B EUR
Gross Profit871.61M EUR
Net Income (TTM)46.15M EUR
Revenue/Share5.208 EUR
Last Price11.12 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.1K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0157097017
Valuation
P/E (Trailing)58.53
P/E (Forward)20.33
PEG1.00
EV/EBITDA12.10
EV/Revenue2.16
P/S2.18
P/B1.64
EPS (TTM)0.19
EPS (Forward)0.56
52W Range
10.0627% of range13.98
52W High13.98 EUR
52W Low10.06 EUR
Profitability
Gross Margin78.66%
Oper. Margin10.26%
EBITDA Margin17.83%
Profit Margin4.17%
ROE3.10%
ROA1.97%
Growth
Revenue Growth2.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF174.46M EUR
CapEx (TTM)137.31M EUR
FCF Margin0.56%
FCF Yield0.26%
Net Debt-25.80M EUR
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.23
Current Ratio2.31
Quick Ratio1.57
Book Value/Sh6.924 EUR
Cash/Share1.449 EUR
Dividends
Fwd Div Rate0.1900 EUR
Trail. Div Rate0.1900 EUR
Div. Yield1.60%
5Y Avg Yield1.83%
Payout Ratio98.57%
Ex-Div DateMay 14, 2026
Pay Date—
Splits
Last Split47:46
Split DateSep 14, 2020
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)14.57 EUR
Target Range12.50 EUR – 17.50 EUR
# Analysts12
Ownership
Shares Out.214.63M
Float75.28M
Insiders64.96%
Institutions18.39%
Technical
SMA 5012.09 (-8.0%)
SMA 20012.25 (-9.2%)
Beta0.20
S&P 52W Chg27.94%
Avg Vol (30d)123.58K
Avg Vol (10d)131.48K
Technical Indicators
RSI (14)39.0
MACD-0.2208
MACD Signal-0.2352
MACD Hist.+0.0145
BB Upper12.53 EUR
BB Middle11.73 EUR
BB Lower10.92 EUR
BB Width13.72%
ATR (14)0.3293 EUR
Vol Ratio (20d)1.63x